FIELD: pharmaceuticals; medicine; ophthalmology.
SUBSTANCE: invention is intended for treating macular edema. Pharmaceutical composition for treating macular edema contains an integrin-inhibiting peptide, which consists of Glicinyl-Arginyl-Glycynyl-Cysteic acid-Threonyl-Proline-COOH or a pharmaceutically acceptable salt thereof. In one embodiment, said peptide is a linear peptide and has the structural formula: ![](/patent/RU2721907C2/i/00000056.png)
EFFECT: use of the invention provides macular edema treatment by inhibiting angiogenesis.
11 cl, 8 tbl, 11 dwg
Title |
Year |
Author |
Number |
COMPOSITIONS AND METHODS FOR INHIBITION OF CELLULAR ADHESION OR DIRECTION OF DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES |
2010 |
- Mackel Michael John
- Park John
|
RU2642625C2 |
COMPOSITIONS AND METHODS FOR ANGIOGENESIS SUPPRESSION |
2010 |
- Mekel Majkl Dzhon
- Park Dzhon
|
RU2786127C2 |
PEPTIDES FOR INHIBITING ANGIOGENESIS |
2016 |
- Komarova Yulia A.
- Rosenblatt Mark
- Malik Asrar B.
|
RU2708375C2 |
USE OF VEGF ANTAGONIST FOR TREATING RETINOPATHY OF PREMATURITY |
2014 |
- Buryan Gabriela
- Aksenov Sergej
|
RU2676303C2 |
MEANS FOR TREATMENT OF DISEASE WITH MACULAR OEDEMA DUE TO EXCESSIVE VEGF-A EXPRESSION |
2016 |
- Shuster Aleksandr Mikhajlovich
- Khamitov Ravil Avgatovich
- Abbasova Svetlana Georgievna
- Fabrichnyj Igor Pavlovich
- Poteryaev Dmitrij Aleksandrovich
- Bade Veronika Nikolaevna
|
RU2669787C2 |
LIPOSOMAL PREPARATIONS |
2013 |
- Santos, Arturo
- Frost, Fillip
|
RU2817350C2 |
LIPOSOME FORMULATIONS |
2013 |
- Santos Arturo
- Frost Phillip
|
RU2680096C2 |
FLUORINE-CONTAINING INTEGRIN ANTAGONISTS |
2014 |
- Askyu Ben S.
- Khajdebrekht Richard V.
- Furuya Takeru
- Daggen Mark E.
- Edvards D. Skott
|
RU2698195C2 |
APPLICATION OF ANTAGONIST VEGF IN TREATMENT OF CHORIORETINAL NEOVASCULAR DISTURBANCES AND DISORDERS OF PENETRATION IN PEDIATRIC PATIENTS |
2014 |
- Aksenov Sergej
- Buryan Gabriela
|
RU2676274C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING EYE DISEASES, CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TISSUE-PENETRATING PEPTIDE AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PREPARATION ARE FUSED |
2016 |
- Kim, Seong Beom
- Jung, Hyei Yoon
- Yang, Seok Woo
- Kwon, Hyuk Sang
- Kang, Jae-Hoon
|
RU2712623C2 |